PM360

JUNE 23, 2023

Press Release Contact: Kayla Walsh Awards Coordinator, PM360 646-300-8114 kayla.walsh@pm360online.com PM360 Now Accepting Entries for 2024 Pharma Choice Awards Call for the Best Healthcare Creative from the Past Year NEW YORK, NY, June 22, 2023 : The 2024 PM360 Pharma Choice Awards are officially open for entries.

Pharma 52

Pharma Marketing Healthcare Healthcare 52

Spotio

JANUARY 23, 2024

Dallas, TX – January 23, 2024 – SPOTIO, the leader in field sales engagement technology, and Solo, the all-in-one solar growth and proposal platform, are excited to announce an enhanced native integration that will redefine efficiency and effectiveness in the solar sales sector.

Sales experience 52

Sales experience Sales Leads Engineering 52

PM360

FEBRUARY 8, 2024

THE ELEVATE HEALTHCARE MEMBERS: Scott Harper VP, Client Engagement Matt Parastino Assistant Manager, Client Engagement Tara Powers VP Creative Director, Art Sarah Ward Art Group Supervisor Carolyn Ignomirello Creative Director, Copy Tina Wack Copy Supervisor Derick Sumrall Practice Lead, Customer Experience LIVANOVA USA, INC.

Pharma 52

Pharma Sales Management Healthcare 52

Quantified

FEBRUARY 7, 2024

Traditional sales training is hitting a roadblock. It may still provide sound fundamental skills to sales agents new to the profession or your organization, but it’s not designed for a modern workforce or modern buyers requiring individualized approaches. Fortunately, sales AI simulators are ready to fill that gap.

Training 52

Training Sales Sales Management Management 52

Spotio

NOVEMBER 20, 2023

This sales model has many different advantages. At the end of the day, distributors simplify the sales process for manufacturers. Others use specific methods to ensure more sales. In other words, you need to select sales channels for yourself and/or your sales team. Why Sell To Distributors?

Retail 52

Retail Distribution Sales Manufacturing 52

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. What’s leading to the boom in development of semaglutide biosimilars? Per recent Clarivate estimates, the therapeutic market for these drugs is valued at approximately $1.7

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

PM360

DECEMBER 12, 2023

The initial deadline for submissions is February 23, 2024. PM360 will then continue to accept entries until March 15, 2024, but anything after Feb. Established a decade ago, the PM360 ELITE honors 100 of the top individuals and marketing teams across the healthcare and life sciences industries each year.

Education 52

Education Healthcare Healthcare Marketing 52

PM360

NOVEMBER 14, 2023

This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. retail pharmacies to access a 30-day supply of Lantus for only $35. General Medicines at Sanofi. “We

Retail 52

Retail Pharmaceutical manufacturing Sales Insurance 52

PM360

SEPTEMBER 21, 2023

Over the next few weeks, manufacturers will submit a range of clinical, marketing, sales, pricing, and patient data, and then meet with CMS to discuss submissions later this fall. CMS will present an initial offer for each drug’s maximum fair price (MFP) by February 1, 2024.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Pharmaceutical Technology

JUNE 21, 2023

PharmaTher plans to file an abbreviated new drug application with the FDA for Ketarx in July 2023, and to secure approval in the first quarter of 2024. The company and Vitruvias are planning pre-launch activities, including distribution, trade relations, pricing, marketing, and managed care and sales plans.

Distribution 52

Distribution FDA Specialization Sales 52

Spotio

APRIL 11, 2023

If you’re a sales manager in the roofing industry, you know how competitive it can be. million squares in 2024. A roofing CRM is a customer relationship management tool that helps roofers track leads, communicate with prospects, drive revenue, and otherwise manage the roofing sales process. per year, reaching 164.1

CRM 52

CRM Sales Prospecting Sales process 52

Pharmaceutical Technology

MAY 19, 2023

will be paid in equal quarterly instalments in 2024. EyePoint Pharmaceuticals will also receive potential royalties on the combined net sales of Iluvien and Yutiq in the US from 2025 to 2028. The company made a $75m up-front cash payment to EyePoint Pharmaceuticals on the closure of the deal, and an additional $7.5m

Food and Drug Administration 52

Food and Drug Administration Food Pharmaceutical Sales 52

Pharmaceutical Technology

MAY 25, 2023

As a leading global biopharmaceutical company, we are leveraging our unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to expand the availability of high-quality biosimilars for US patients.” It represents a key treatment option in patient care and patient choice. “As

Food and Drug Administration 52

Food and Drug Administration FDA Food Safety 52

pharmaphorum

JANUARY 9, 2023

Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 Additionally, its top-selling drug, Myalept or Myalepta, had third-quarter sales of $37.9m. in an all-cash transaction at $14.50

Pharma 85

Pharma Biopharma Management Medicine 85

Quantified

JANUARY 15, 2024

Sales kickoff (SKO) events address many different objectives, such as energizing the sales team, communicating goals, and keeping everyone up to date on product releases. However, conventional sales role-play exercises have other challenges ranging from low engagement to the time demands they place on trainers.

Training 52

Training Sales Prospecting Management 52

Legacy MEDSearch

SEPTEMBER 13, 2023

Food and Drug Administration (FDA) via the 510(k) pathway, with potential clearance expected during the first half of 2024. Legacy systems for breathing assistance are causing multiple complications leading to physical damage, infection and possible death.

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Pharmaceutical Technology

FEBRUARY 28, 2023

Xinvento will also receive up to $150m in certain commercial net sales milestones related to the lead product or a second molecule in the event of a second molecule’s selection, development and approval. We look forward to entering the clinic with a new therapeutic candidate in 2024.”

Pharmaceutical 52

Pharmaceutical Sales Leads 52

pharmaphorum

JANUARY 9, 2023

Albireo secured approval in the US and Europe for the ileal bile acid transport inhibitor (IBATi) drug in 2021 for the treatment of pruritus (itching) in patients with rare disorder progressive familial intrahepatic cholestasis (PFIC), and has said sales should reach $24 million this year. billion deal.

Transportation 52

Transportation Sales Leads FDA 52

European Pharmaceutical Review

SEPTEMBER 21, 2023

“A Grand Bargain is both achievable and in everyone’s interest to overcome the collective actions problems inherent in dealing with market failures in the antimicrobial market,” stated Anthony McDonnell, lead author of the report and a senior policy analyst at the CGD.

Pharma 95

Pharma Government Marketing Manufacturing 95

Pharmaceutical Technology

MAY 16, 2023

This comes with an upfront cash payment of $375 million, with a potential additional $25 million if Hemgenix net sales reach a certain milestone in 2024, based on a May 15 announcement. Additionally, UniQure was set to get tiered royalties of up to “a low-twenties percentage” of net product sales related to Hemgenix.

Food and Drug Administration 52

Food and Drug Administration Healthcare Healthcare Sales 52

pharmaphorum

OCTOBER 10, 2022

Australian biotech Immutep’s LAG-3 checkpoint inhibitor eftilagimod alpha (efti) may not be the first drug in the class to reach the market, but is a strong contender and, according to at least one analyst, is on course for multibillion-dollar peak sales. Also in its favour is that LAG-3 is now a tried and tested target.

Side effects 57

Side effects Sales Marketing FDA 57

Legacy MEDSearch

MAY 26, 2023

From 2024, Biosency will make its BVS 3 technology available to healthcare professionals for integration into the BORA Care® digital medical device, with the aim of obtaining reimbursement as part of an advance payment scheme. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. It resulted in 3.23

Medical 52

Medical Recruitment Management Patients 52

Pharmaceutical Technology

MAY 30, 2023

Maselli also cited non-manufacturing factors in Catalent’s poor performance and incorrect forecasting, especially a revenue cliff as the pandemic recedes: Catalent’s Covid-related sales will decline by more than 50% compared with last year, he said, and will be even lower in 2024.

Manufacturing 52

Manufacturing FDA Sales Leads 52

Pharmaceutical Technology

APRIL 4, 2023

While Scorpion will lead the development of STX-721, Pierre Fabre will handle STX-241. The Boston, Massachusetts-based Scorpion expects to submit an investigational new drug (IND) application for STX-721 to the US Food and Drug Administration (FDA) in mid-2023, with an IND application for STX-241 expected in H1 2024. Up to 12.5%

Food and Drug Administration 52

Food and Drug Administration Biopharma FDA Pharmaceutical 52

Pharmaceutical Technology

JANUARY 10, 2023

billion in sales in 2019, increasing to $136.2 billion in 2029, with drug sales almost doubling at a compound annual growth rate (CAGR) of 11.5%. Mounjaro is forecast to compete for significant market share with semaglutide and also Lilly’s Trulicity (dulaglutide), reaching peak sales of $10.2

Marketing 52

Marketing Physicians Leads Sales 52

pharmaphorum

DECEMBER 20, 2022

Wedbush Securities recently forecast more than $1 billion in 2029 sales for ensifentrine in the US alone, assuming a launch in the first quarter of 2024, and said today the stock could easily reach $30. COPD is the third leading cause of death worldwide, with 3.23 and drive the company’s market cap to almost $1.5

Pharma 57

Pharma Sales Leads Marketing 57

Clarivate

MAY 24, 2022

Some of our bold, ambitious goals include achieving carbon neutrality by 2024 with our sights on achieving a net-zero future as members of the “Business Ambition for 1.5” Tiffani is also responsible for the Customer Care, Sales Experience and Operations teams. Tiffani Shaw, Chief of Staff. Driving real, measurable change.

Government 98

Government Education Sales experience Leads 98

pharmaphorum

SEPTEMBER 27, 2022

The emergence of PD-(L1) treatments has provided patients options where previously none existed, and the leading forms of these therapies have gone on to blockbuster sales. An example of this is Merck’s Keytruda (pembrolizumab), a PD-1 checkpoint inhibitor that brought in full year 2021 sales of $17.2

Leads 80

Leads Sales Patients Pharma 80

Legacy MEDSearch

MAY 9, 2023

They developed the Virtuoso Surgical system with a design team helmed by COO and Lead Engineer Richard Hendrick, PhD. Company executives anticipate regulatory submission in 2024, pursuant of FDA approval for sale in the United States. This device has not yet been approved by the FDA and is not for sale in the United States.

Recruitment 52

Recruitment Engineering Sales Medical 52

Legacy MEDSearch

AUGUST 21, 2023

Muratoglu invented the first crosslinked polyethylene, and the first of multiple generations of vitamin E, antioxidant polyethylene for leading orthopaedic companies. “We Global expansion will begin in 2024. This new generation polyethylene is the latest, first-of-a-kind innovation by Orhun Muratoglu, Ph.D.,

Food and Drug Administration 52

Food and Drug Administration FDA Recruitment Marketing 52

Legacy MEDSearch

AUGUST 17, 2023

This enhanced functionality will be made available commercially in 2024. The receipt of our 10 th 510(k) clearance is another milestone demonstrating Welldoc’s commitment to leading innovation in digital health. Our clients include both blue-chip companies and innovative startups within the MedTech space.

FDA 52

FDA Food and Drug Administration Recruitment Management 52

Quantified

OCTOBER 16, 2023

Artificial intelligence is reshaping how sales organizations across every industry are doing business. It can increase revenue by speeding up response times, improving marketing and outreach with more personalized communications, and boosting closed-won rates by giving a sales team better insight into leads.

Sales technology 52

Sales technology Sales Training Leads 52

Spotio

JANUARY 9, 2024

Solar proposal software allows folks in the solar industry to streamline the solar sales process. The resulting document can then be distributed, so leads have the necessary data to make a buying decision. More Sales : At the end of the day, solar proposal tools help close more deals. It makes sense. ” WAY more!

Prospecting 52

Prospecting Sales Distribution Sales process 52

pharmaphorum

SEPTEMBER 14, 2022

That’s according to a Bloomberg report , which claims Bayer has started the search for a successor well ahead of the end of Baumann’s current contract in April 2024. Now, it seems his time at the top may be coming to an end.

Pharma 86

Pharma Management Leads Marketing 86

PM360

APRIL 7, 2023

Dan Renick The IRA presents market access teams with a unique opportunity to make recommendations to CMS regarding the evidence and methodology that will be applied in evaluating drugs for upcoming Medicare negotiations that will lead to price adjustments in 2026. Given the volume of 340B sales (13% of total U.S.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

PM360

DECEMBER 14, 2023

For 12 years, PM360 , a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has recognized the most ground-breaking innovations of this industry as well as from other organizations that serve the life sciences and healthcare in its annual Innovations Issue.

Insurance 64

Insurance Marketing Healthcare Healthcare 64

Evolve Your Success

AUGUST 22, 2023

Adaptability, positivity, and strong relationships are the heartbeat of success in maternal infant care product sales. She shares insights, challenges, and triumphs that have defined her path in the medical sales industry. It’s another person that’s doing amazing things in the medical sales space. She’s based in Los Angeles.

Sales 52

Sales Medical sales Networking Medical 52